Danaher-IGI Beacon for CRISPR Cures


2200 Pennsylvania Ave, NW Suite 800W

Washington, DC 20037

Company Info

Year Established
2024

Contacts

Jennifer Doudna
Co-Founder & Director

Company Description

Danaher-IGI Beacon for CRISPR Cures, aims to use CRISPR-based gene editing to permanently address hundreds of diseases with a unified research, development and regulatory approach.